Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

Iksuda Therapeutics

www.iksuda.com

Herschel Annex
Kings Gate
Newcastle upon Tyne
NE1 7RU
United Kingdom

Activities

Research & Development | Pharmaceutical

Related Companies

  • Lonza
  • Icrom SRL
  • Nanoform
  • Merck Life Science KGaA
  • Starlab
  • Edwards Vacuum
  • PCI Pharma Services
  • Solvias
  • Piramal Pharma Solutions
  • Butterworth Laboratories
  • Hermes Pharma GmbH
  • Ecolab Life Sciences
  • Marchesini Group
  • Vectorbuilder Inc
  • Rentschler Biopharma SE
  • Indena
  • Quotient Sciences
  • ProtaGene
  • Actylis – The Partner of Choice

Related Content

LegoChem and Iksuda expand ADC license agreement
LegoChem and Iksuda expand ADC license agreement
ADC developer Iksuda Therapeutics closes $47m financing round
ADC developer Iksuda Therapeutics closes $47m financing round
Iksuda releases first data on ADC efficacy on tumour regression
Iksuda releases first data on ADC efficacy on tumour regression
Iksuda and Femtogenix ink solid tumour agreement
Iksuda and Femtogenix ink solid tumour agreement
Glythera announces corporate name change and rebranding
Glythera announces corporate name change and rebranding
Glythera appoints Professor Kerry Chester to SAB
Glythera appoints Professor Kerry Chester to SAB
Glythera appoints Chief Scientific Officer and strengthens SAB
Glythera appoints Chief Scientific Officer and strengthens SAB
Glythera and Cancer Research UK announce licence agreement
Glythera and Cancer Research UK announce licence agreement
Glythera appoints Dr Mike Owen as Non-Executive Director
Glythera appoints Dr Mike Owen as Non-Executive Director
Glythera launch project to bring new oncology focused therapies
Glythera launch project to bring new oncology focused therapies
Glythera appoints Scientific Advisory Board
Glythera appoints Scientific Advisory Board
Avacta to collaborate with Glythera to develop antibody-drug conjugates
Avacta to collaborate with Glythera to develop antibody-drug conjugates
Glythera makes two senior appointments
Glythera makes two senior appointments
BioOutsource partners Glythera to expand ADC characterisation capabilities
BioOutsource partners Glythera to expand ADC characterisation capabilities
UK biotechnology firm Glythera receives funding boost of £700,000
UK biotechnology firm Glythera receives funding boost of £700,000
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company